Early angiography in patients with chronic kidney disease: a collaborative systematic review.
暂无分享,去创建一个
E. Braunwald | C. Cannon | R. D. de Winter | L. Wallentin | N. Choudhry | D. Charytan | B. Lagerqvist | Noam M Stern | R. Spacek
[1] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[2] L. Wallentin,et al. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease. , 2006, American heart journal.
[3] D. Charytan,et al. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. , 2006, Kidney international.
[4] L. Mauri,et al. The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients. , 2006, American heart journal.
[5] Tom Greene,et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.
[6] S. King. Do elderly patients with non-ST-segment elevation acute coronary syndromes benefit from early invasive treatment? , 2006, Nature Clinical Practice Cardiovascular Medicine.
[7] J. Yee,et al. Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. , 2005, Clinical nephrology.
[8] D. Hu,et al. [The effect of early invasive strategy on early and late outcomes in high-risk non-ST-segment elevation acute coronary syndromes]. , 2005, Zhonghua nei ke za zhi.
[9] J. Tijssen,et al. Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.
[10] S. Yusuf,et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. , 2005, JAMA.
[11] A. Detsky,et al. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials. , 2005, The American journal of medicine.
[12] Kyung Sun,et al. Stenting or MIDCAB using ministernotomy for revascularization of proximal left anterior descending artery? , 2005, International journal of cardiology.
[13] A. Mügge,et al. Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up. , 2005, International journal of cardiology.
[14] B. Davis,et al. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. , 2004, Journal of the American College of Cardiology.
[15] Robert M Califf,et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.
[16] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[17] B. McNeil,et al. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. , 2004, Journal of the American Society of Nephrology : JASN.
[18] A. Kastrati,et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. , 2003, JAMA.
[19] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[20] S. Borzak,et al. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. , 2003, The American journal of cardiology.
[21] M. Pfisterer,et al. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. , 2003, JAMA.
[22] S. Murphy,et al. THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Management of Heart Failure and Coronary Artery Disease in Patients with Chronic Kidney Disease , 2003, Seminars in dialysis.
[23] W. Boden. "Routine invasive" versus "selective invasive" approaches to non-ST-segment elevation acute coronary syndromes management in the post-stent/platelet inhibition era. , 2003, Journal of the American College of Cardiology.
[24] K. Fox,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.
[25] T. Shaw,et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. , 2002, Lancet.
[26] R. Califf,et al. Prognostic Implications of Abnormalities in Renal Function in Patients With Acute Coronary Syndromes , 2002, Circulation.
[27] P. Widimsky,et al. Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO study☆ , 2002 .
[28] Colin B Begg,et al. A comparison of methods to detect publication bias in meta‐analysis by P. Macaskill, S. D. Walter and L. Irwig, Statistics in Medicine, 2001; 20:641–654 , 2002, Statistics in medicine.
[29] Kirk N. Garratt,et al. Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.
[30] R. Califf,et al. Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation , 2002, Circulation.
[31] M. Kinoshita,et al. Long-term outcome of primary percutaneous transluminal coronary angioplasty for low-risk acute myocardial infarction in patients older than 80 years: a single-center, open, randomized trial. , 2002, American heart journal.
[32] P. Widimsky,et al. Value of first day angiography/angioplasty in evolving Non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. , 2002, European heart journal.
[33] P. Campbell. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes. , 2001, The New England journal of medicine.
[34] C. Vassanelli,et al. [Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[35] A. Kastrati,et al. Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen. , 2001, Journal of the American College of Cardiology.
[36] H. Yip,et al. Comparison of impact of primary percutaneous transluminal coronary angioplasty and primary stenting on short-term mortality in patients with cardiogenic shock and evaluation of prognostic determinants. , 2001, The American journal of cardiology.
[37] A. Langer,et al. Prognostic value of dipyridamole SPECT imaging in low-risk patients after myocardial infarction , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[38] S D Walter,et al. A comparison of methods to detect publication bias in meta‐analysis , 2001, Statistics in medicine.
[39] L. Michalis,et al. Treatment of refractory unstable angina in geographically isolated areas without cardiac surgery. Invasive versus conservative strategy (TRUCS study). , 2000, European heart journal.
[40] H. Suryapranata,et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. , 2000, European heart journal.
[41] I. Olkin,et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.
[42] R. Kleiger,et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. , 1999, The New England journal of medicine.
[43] F. Ragmin. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.
[44] W. O’Neill,et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. , 1998, Journal of the American College of Cardiology.
[45] R. Kleiger,et al. Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.
[46] W. O’Neill,et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.
[47] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[48] A. Zeiher,et al. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty. , 1996, The American journal of cardiology.
[49] C. Cannon,et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. , 1995, Journal of the American College of Cardiology.
[50] D. Goff,et al. Non-invasive management of coronary artery disease , 1995, The Lancet.
[51] J. S. Chen,et al. Regression of left ventricular aneurysm after delayed percutaneous transluminal coronary angioplasty (PTCA) in patients with acute myocardial infarction. , 1995, International journal of cardiology.
[52] J. Mcmanus. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .
[53] L. Wilkins. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.
[54] K. Bailey,et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. , 1993, The New England journal of medicine.
[55] J. Reiber,et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. , 1993, The New England journal of medicine.
[56] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[57] L. Shaw,et al. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial. , 1993, The American journal of cardiology.
[58] W. O’Neill,et al. A Prospective, Placebo‐Controlled, Randomized Trial of Intravenous Streptokinase and Angioplasty Versus Lone Angioplasty Therapy of Acute Myocardial Infarction , 1992, Circulation.
[59] F. Verheugt,et al. [Optimal therapy following thrombolysis: aggressively or conservatively?]. , 1989, Nederlands tijdschrift voor geneeskunde.
[60] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[61] S. Scott,et al. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. , 1987, The New England journal of medicine.
[62] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[63] J. T. Shepherd,et al. Fibrinolytic therapy in unstable angina pectoris. A controlled clinical trial. , 1980, Thrombosis research.
[64] W. G. Cochran. The combination of estimates from different experiments. , 1954 .
[65] G. Eknoyan,et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[66] G. Specchia,et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.
[67] ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[68] L. Wallentin,et al. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .
[69] Bias in meta›analysis detected by a simple, graphical test , 1998 .
[70] D. Goff,et al. Non-invasive management of coronary artery disease. Report of a meeting at the University of Texas Medical School at Houston. , 1995, Lancet.
[71] Frans Van de Werf,et al. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.